Effects of a new algae protein on muscle protein synthesis in older adults
Ingestion of a Novel Algae Protein Source on Rested and Post Exercise Muscle Protein Synthesis Rates.
This study tests if a new algae protein can help older adults build muscle better than regular whey protein.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 15 (estimated) |
| Ages | 65 Years to 80 Years |
| Sex | All |
| Sponsor | University of Exeter Academic / other |
| Locations | 1 site (Exeter) |
| Trial ID | NCT06852547 on ClinicalTrials.gov |
What this trial studies
This study evaluates how a novel, flavorless algae protein source affects muscle protein synthesis rates in older adults, both at rest and after exercise. Participants will ingest this algae protein and its effects will be compared to those of traditional whey protein. The focus is on older adults aged 65-80 who are recreationally active, aiming to understand the potential benefits of this alternative protein source for muscle health.
Who should consider this trial
Good fit: Ideal candidates are males and females aged 65-80 with a BMI between 18.5 and 30 who are recreationally active.
Not a fit: Patients with metabolic or cardiovascular impairments, gastrointestinal disorders, or those on medications affecting protein metabolism may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide older adults with a beneficial protein source that enhances muscle health and recovery.
How similar studies have performed: While there is ongoing research into alternative protein sources, this specific approach using algae protein in older adults is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Males and Females BMI 18.5 - 30 kg/m2 Aged 65-80 years Recreationally Active Exclusion Criteria: Body mass index (BMI) \<18.5 or \>30 kg/m2 Any metabolic impairments Any cardiovascular impairments High blood pressure (≥140/90 mmHg) Any gastrointestinal disorders Any medications known to affect protein and/or amino acid metabolism A personal or family history of epilepsy, seizures or schizophrenia, motor disorder Chronic over the counter use of pharmaceuticals (\> 1 month) Allergic to any of the whole foods included in the study
Where this trial is running
Exeter
- Health and Life Sciences — Exeter, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Freyja A.D Haigh, PhD
- Email: fh357@exeter.ac.uk
- Phone: +447917608163
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.